Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels

  1. Jacqueline Niu
  2. Ivy E Dick
  3. Wanjun Yang
  4. Moradeke A Bamgboye
  5. David T Yue
  6. Gordon Tomaselli
  7. Takanari Inoue  Is a corresponding author
  8. Manu Ben-Johny  Is a corresponding author
  1. Johns Hopkins University, United States
  2. University of Maryland, United States
  3. Columbia University Medical Center, United States

Abstract

Calmodulin (CaM) serves as a pervasive regulatory subunit of CaV1, CaV2, and NaV1 channels, exploiting a functionally-conserved carboxy-tail element to afford dynamic Ca2+-feedback of cellular excitability in neurons and cardiomyocytes. Yet this modularity counters functional adaptability, as global changes in ambient CaM indiscriminately alter its targets. Here, we demonstrate that two structurally-unrelated proteins, SH3 and cysteine-rich domain (stac) and fibroblast growth factor homologous factors (fhf) selectively diminish Ca2+/CaM-regulation of CaV1 and NaV1 families respectively. The two proteins operate on allosteric sites within upstream portions of respective channel carboxy-tails, distinct from CaM-binding interface. Generalizing this mechanism, insertion of a short RxxK binding motif into CaV1.3 carboxy-tail, confers synthetic switching of CaM regulation by Mona SH3 domain. Overall, our findings identify a general class of auxiliary proteins that modify Ca2+/CaM signaling to individual targets allowing spatial and temporal orchestration of feedback, and outline strategies for engineering Ca2+/CaM signaling to individual targets.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Jacqueline Niu

    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ivy E Dick

    Department of Physiology, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Wanjun Yang

    Department of Cardiology, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Moradeke A Bamgboye

    Department of Physiology, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. David T Yue

    Department of Biomedical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Gordon Tomaselli

    Department of Cardiology, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Takanari Inoue

    Department of Cell Biology, Johns Hopkins University, Baltimore, United States
    For correspondence
    jctinoue@jhmi.edu
    Competing interests
    The authors declare that no competing interests exist.
  8. Manu Ben-Johny

    Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States
    For correspondence
    mbj2124@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5645-0815

Funding

National Institute of Mental Health

  • David T Yue
  • Manu Ben-Johny

National Heart, Lung, and Blood Institute

  • Gordon Tomaselli
  • Manu Ben-Johny

National Science Foundation

  • Jacqueline Niu

National Institute of Neurological Disorders and Stroke

  • Ivy E Dick
  • David T Yue

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the Johns Hopkins University (GP15M172). The protocol was approved by the Committee on the Ethics of Animal Experiments of the Johns Hopkins University. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Copyright

© 2018, Niu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,790
    views
  • 321
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jacqueline Niu
  2. Ivy E Dick
  3. Wanjun Yang
  4. Moradeke A Bamgboye
  5. David T Yue
  6. Gordon Tomaselli
  7. Takanari Inoue
  8. Manu Ben-Johny
(2018)
Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels
eLife 7:e35222.
https://doi.org/10.7554/eLife.35222

Share this article

https://doi.org/10.7554/eLife.35222

Further reading

    1. Neuroscience
    2. Structural Biology and Molecular Biophysics
    Yangyu Wu, Yangyang Yan ... Fred J Sigworth
    Research Article

    We present near-atomic-resolution cryoEM structures of the mammalian voltage-gated potassium channel Kv1.2 in open, C-type inactivated, toxin-blocked and sodium-bound states at 3.2 Å, 2.5 Å, 3.2 Å, and 2.9 Å. These structures, all obtained at nominally zero membrane potential in detergent micelles, reveal distinct ion-occupancy patterns in the selectivity filter. The first two structures are very similar to those reported in the related Shaker channel and the much-studied Kv1.2–2.1 chimeric channel. On the other hand, two new structures show unexpected patterns of ion occupancy. First, the toxin α-Dendrotoxin, like Charybdotoxin, is seen to attach to the negatively-charged channel outer mouth, and a lysine residue penetrates into the selectivity filter, with the terminal amine coordinated by carbonyls, partially disrupting the outermost ion-binding site. In the remainder of the filter two densities of bound ions are observed, rather than three as observed with other toxin-blocked Kv channels. Second, a structure of Kv1.2 in Na+ solution does not show collapse or destabilization of the selectivity filter, but instead shows an intact selectivity filter with ion density in each binding site. We also attempted to image the C-type inactivated Kv1.2 W366F channel in Na+ solution, but the protein conformation was seen to be highly variable and only a low-resolution structure could be obtained. These findings present new insights into the stability of the selectivity filter and the mechanism of toxin block of this intensively studied, voltage-gated potassium channel.

    1. Structural Biology and Molecular Biophysics
    Kazi A Hossain, Lukasz Nierzwicki ... Giulia Palermo
    Research Article

    xCas9 is an evolved variant of the CRISPR-Cas9 genome editing system, engineered to improve specificity and reduce undesired off-target effects. How xCas9 expands the DNA targeting capability of Cas9 by recognising a series of alternative protospacer adjacent motif (PAM) sequences while ignoring others is unknown. Here, we elucidate the molecular mechanism underlying xCas9’s expanded PAM recognition and provide critical insights for expanding DNA targeting. We demonstrate that while wild-type Cas9 enforces stringent guanine selection through the rigidity of its interacting arginine dyad, xCas9 introduces flexibility in R1335, enabling selective recognition of specific PAM sequences. This increased flexibility confers a pronounced entropic preference, which also improves recognition of the canonical TGG PAM. Furthermore, xCas9 enhances DNA binding to alternative PAM sequences during the early evolution cycles, while favouring binding to the canonical PAM in the final evolution cycle. This dual functionality highlights how xCas9 broadens PAM recognition and underscores the importance of fine-tuning the flexibility of the PAM-interacting cleft as a key strategy for expanding the DNA targeting potential of CRISPR-Cas systems. These findings deepen our understanding of DNA recognition in xCas9 and may apply to other CRISPR-Cas systems with similar PAM recognition requirements.